• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阐述用于清除肾衰竭患者血液中肽的免疫化学方法的途径]

[Approach to elaborating immunochemical methods for removing peptides from the blood of kidney failure patients].

作者信息

Sadykov A S, Salikhov Sh I, Mikhamedieva Sh G, Kasymov Sh K, Pak N P

出版信息

Biull Eksp Biol Med. 1984 Aug;98(8):245-7.

PMID:6466865
Abstract

A homogenic peptide (m. w. 2100 dalton) was isolated from blood serum of patients suffering from renal failure by gel chromatography on a Sephadex G-25 column and by partition chromatography on a column with cellulose MN-300. The peptide was not detectable in the blood of healthy donors. The amino acid composition of the peptide was studied. To obtain an immunosorbent, the peptide was conjugated by the bifunctional reagent, glutaric aldehyde. An optimal conjugation variant promoting the formation of conjugates with a molecular weight of 60000 dalton was developed. The molecular weight of the conjugates was measured by gel chromatography on a Sephadex column G-50 and with the aid of disc electrophoresis in polyacrylamide gel.

摘要

通过在Sephadex G - 25柱上进行凝胶色谱法以及在装有纤维素MN - 300的柱上进行分配色谱法,从肾衰竭患者的血清中分离出一种同源肽(分子量2100道尔顿)。在健康供体的血液中未检测到该肽。对该肽的氨基酸组成进行了研究。为了获得免疫吸附剂,用双功能试剂戊二醛将该肽进行偶联。开发出了一种促进形成分子量为60000道尔顿的偶联物的最佳偶联变体。通过在Sephadex G - 50柱上进行凝胶色谱法以及借助聚丙烯酰胺凝胶中的圆盘电泳来测定偶联物的分子量。

相似文献

1
[Approach to elaborating immunochemical methods for removing peptides from the blood of kidney failure patients].[阐述用于清除肾衰竭患者血液中肽的免疫化学方法的途径]
Biull Eksp Biol Med. 1984 Aug;98(8):245-7.
2
Chromatographic studies of uremic plasma.尿毒症血浆的色谱研究。
Int J Artif Organs. 1979 Jul;2(4):187-91.
3
Isolation of the homogeneous constituents from non-diffusible sugar-peptide (NSP) fraction originating from bovine plasma. III. The method of isolation and partial characterization of the four peptide constituents.从源自牛血浆的非扩散性糖肽(NSP)组分中分离均一成分。III. 四种肽成分的分离方法及部分特性鉴定
Folia Histochem Cytochem (Krakow). 1983;21(1):3-14.
4
Micropreparative gel electrophoresis of low-molecular-weight peptides: purification of highly insoluble amyloid peptide fragments.低分子量肽的微量制备凝胶电泳:高度不溶性淀粉样肽片段的纯化
Anal Biochem. 1996 May 1;236(2):191-8. doi: 10.1006/abio.1996.0156.
5
[The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].[通过血液中分子组分谱评估传出疗法对急慢性肾衰竭患者的疗效]
Urol Nefrol (Mosk). 1994 Jul-Aug(4):35-7.
6
Separation, identification of uremic middle molecules, and preliminary study on their toxicity.尿毒症中分子的分离、鉴定及其毒性的初步研究
Clin Chim Acta. 2004 Dec;350(1-2):89-98. doi: 10.1016/j.cccn.2004.07.003.
7
[A quantitative method of determining middle molecule peptides in the blood serum of patients with chronic renal insufficiency].[一种测定慢性肾功能不全患者血清中中分子肽的定量方法]
Lab Delo. 1989(3):48-52.
8
Technical aspects on middle molecules: separation, isolation, and identification.
Artif Organs. 1981;4 Suppl:8-12.
9
Erythropoietic inhibitors in uremic serum.尿毒症血清中的红细胞生成抑制剂。
Clin Invest Med. 1982;5(4):237-40.
10
[Level of peptides in blood serum in experimental traumatic illness].[实验性创伤疾病中血清肽水平]
Vopr Med Khim. 1993 Nov-Dec;39(6):40-2.